Diabetes Care 25:971-976, 2002
© 2002 by the American Diabetes Association, Inc.
Epidemiology/Health Services/Psychosocial Research Original Article |
Young Men With High-Normal Blood Pressure Have Lower Serum Adiponectin, Smaller LDL Size, and Higher Elevated Heart Rate Than Those With Optimal Blood Pressure
Tsutomu Kazumi, MD, PHD1,
Akira Kawaguchi, MD, PHD2,
Keiko Sakai, MD3,
Tsutomu Hirano, MD, PHD3 and
Gen Yoshino, MD, PHD4
1 Department of Medicine, Hyogo Rehabilitation Center Hospital, Kobe, Japan
2 Health Science Center, Kobe University of Mercantile Marine, Kobe, Japan
3 First Department of Internal Medicine, Schowa University School of Medicine, Tokyo, Japan
4 Department of Laboratory Medicine, Toho University School of Medicine, Tokyo, Japan
OBJECTIVEThree measuresheart rate, a global index of the influence of the autonomic nervous system on the heart; circulating concentrations of adiponectin, an adipose-specific protein; and C-reactive protein (CRP), a sensitive marker of inflammationhave been reported to be closely associated with insulin resistance. Patients with borderline hypertension are known to be more insulin resistant and dyslipidemic than those with normal blood pressure (BP). BP can be classified into three categories: optimal, normal, and high-normal. The present study examined whether those with high-normal BP have any of these three conditions as compared with those with optimal BP in young healthy men.
RESEARCH DESIGN AND METHODSAnthropometric, blood pressure, heart rate, and blood tests, including tests for adiponectin and CRP, were conducted in 198 male students, ages 1826 years, who had fasted overnight. Insulin resistance (IR) and insulin secretion (ß-cell levels) were calculated using the homeostasis model assessment (HOMA), and LDL size was measured by PAGE.
RESULTSCompared with the 90 men who had optimal BP, the 46 men with high-normal BP had increased heart rate, BMI, percent body fat, and serum leptin levels. In addition, they had greater serum insulin, HOMA IR, and ß-cell levels, lower adiponectin levels, and comparable CRP levels. Furthermore, the 46 men with high-normal BP had higher serum triglyceride and apolipoprotein (apo) B levels, and smaller LDL size; however, there was no difference in LDL and HDL cholesterol and apoA-I between men with optimal and high-normal BP. After adjusting for BMI, differences were still significant in serum adiponectin, heart rate, and LDL particle size. As BP rose, there was an increase in heart rate (BMI-adjusted least square means were 63, 65, and 70 bpm in men with optimal, normal, and high-normal BP, respectively; P = 0.005), whereas serum adiponectin (7.5, 6.6, and 6.4 mg/l; P = 0.007) and LDL particle size (271, 269, and 269 Å; P = 0.008) decreased.
CONCLUSIONSYoung men with high-normal BP have a faster heart rate, lower serum adiponectin levels, and smaller LDL size than men with optimal BP, even after adjustment for BMI. These results suggest the necessity of preventing further development of cardiac and metabolic diseases in young people who have high-normal BP.
Abbreviations: apo, apolipoprotein BP, blood pressure CRP, C-reactive protein DBP, diastolic BP FI, fasting insulin FPG, fasting plasma glucose HOMA, homeostasis model assessment IR, insulin resistance SBP, systolic BP

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. M. Egan, S. D. Nesbitt, and S. Julius
Review: Prehypertension: should we be treating with pharmacologic therapy?
Therapeutic Advances in Cardiovascular Disease,
August 1, 2008;
2(4):
305 - 314.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Barber, M. Hazell, C. Christodoulides, S. J. Golding, C. Alvey, K. Burling, A. Vidal-Puig, N. P. Groome, J. A. H. Wass, S. Franks, et al.
Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
J. Clin. Endocrinol. Metab.,
July 1, 2008;
93(7):
2859 - 2865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Marso, S. K. Mehta, A. Frutkin, J. A. House, J. R. McCrary, and K. R. Kulkarni
Low Adiponectin Levels Are Associated With Atherogenic Dyslipidemia and Lipid-Rich Plaque in Nondiabetic Coronary Arteries
Diabetes Care,
May 1, 2008;
31(5):
989 - 994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Femia, M. Kozakova, M. Nannipieri, C. Gonzales-Villalpando, M. P. Stern, S. M. Haffner, and E. Ferrannini
Carotid Intima-Media Thickness in Confirmed Prehypertensive Subjects: Predictors and Progression
Arterioscler. Thromb. Vasc. Biol.,
October 1, 2007;
27(10):
2244 - 2249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-S. Yang, Y.-C. Yang, C.-L. Chen, I-L. Wu, J.-Y. Lu, F.-H. Lu, T.-Y. Tai, and C.-J. Chang
Adiponectin SNP276 is associated with obesity, the metabolic syndrome, and diabetes in the elderly
Am. J. Clinical Nutrition,
August 1, 2007;
86(2):
509 - 513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. G. Hanley, D. Bowden, L. E. Wagenknecht, A. Balasubramanyam, C. Langfeld, M. F. Saad, J. I. Rotter, X. Guo, Y.-D. I. Chen, M. Bryer-Ash, et al.
Associations of Adiponectin with Body Fat Distribution and Insulin Sensitivity in Nondiabetic Hispanics and African-Americans
J. Clin. Endocrinol. Metab.,
July 1, 2007;
92(7):
2665 - 2671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-S. Chow, B. M.Y. Cheung, A. W.K. Tso, A. Xu, N. M.S. Wat, C. H.Y. Fong, L. H.Y. Ong, S. Tam, K. C.B. Tan, E. D. Janus, et al.
Hypoadiponectinemia as a Predictor for the Development of Hypertension: A 5-Year Prospective Study
Hypertension,
June 1, 2007;
49(6):
1455 - 1461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Minoguchi, T. Yokoe, T. Tazaki, H. Minoguchi, N. Oda, A. Tanaka, M. Yamamoto, S. Ohta, C. P. O'Donnell, and M. Adachi
Silent Brain Infarction and Platelet Activation in Obstructive Sleep Apnea
Am. J. Respir. Crit. Care Med.,
March 15, 2007;
175(6):
612 - 617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Laughlin, E. Barrett-Connor, S. May, and C. Langenberg
Association of Adiponectin with Coronary Heart Disease and Mortality: The Rancho Bernardo Study
Am. J. Epidemiol.,
January 15, 2007;
165(2):
164 - 174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kadowaki, M. Waguri, I. Nakanishi, Y. Miyashita, M. Nakayama, N. Suehara, T. Funahashi, I. Shimomura, and T. Fujita
Adiponectin Concentration in Umbilical Cord Serum Is Positively Associated with the Weight Ratio of Fetus to Placenta
J. Clin. Endocrinol. Metab.,
December 1, 2006;
91(12):
5090 - 5094.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Cavusoglu, C. Ruwende, V. Chopra, S. Yanamadala, C. Eng, L. T. Clark, D. J. Pinsky, and J. D. Marmur
Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain
Eur. Heart J.,
October 1, 2006;
27(19):
2300 - 2309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Minoguchi, T. Yokoe, A. Tanaka, S. Ohta, T. Hirano, G. Yoshino, C. P. O'Donnell, and M. Adachi
Association between lipid peroxidation and inflammation in obstructive sleep apnoea.
Eur. Respir. J.,
August 1, 2006;
28(2):
378 - 385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Sumi, K. Chin, K. Takahashi, T. Nakamura, H. Matsumoto, A. Niimi, and M. Mishima
Effect of nCPAP therapy on heart rate in patients with obstructive sleep apnoea-hypopnoea
QJM,
August 1, 2006;
99(8):
545 - 553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Woo, L. M. Dolan, R. Deka, R. D. Kaushal, Y. Shen, P. Pal, S. R. Daniels, and L. J. Martin
Interactions Between Noncontiguous Haplotypes in the Adiponectin Gene ACDC Are Associated With Plasma Adiponectin
Diabetes,
February 1, 2006;
55(2):
523 - 529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Lawlor, G. Davey Smith, S. Ebrahim, C. Thompson, and N. Sattar
Plasma Adiponectin Levels Are Associated with Insulin Resistance, But Do Not Predict Future Risk of Coronary Heart Disease in Women
J. Clin. Endocrinol. Metab.,
October 1, 2005;
90(10):
5677 - 5683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Minoguchi, T. Yokoe, T. Tazaki, H. Minoguchi, A. Tanaka, N. Oda, S. Okada, S. Ohta, H. Naito, and M. Adachi
Increased Carotid Intima-Media Thickness and Serum Inflammatory Markers in Obstructive Sleep Apnea
Am. J. Respir. Crit. Care Med.,
September 1, 2005;
172(5):
625 - 630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kahn, J. Buse, E. Ferrannini, and M. Stern
The Metabolic Syndrome: Time for a Critical Appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes
Diabetes Care,
September 1, 2005;
28(9):
2289 - 2304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Conus, D. B. Allison, R. Rabasa-Lhoret, M. St-Onge, D. H. St-Pierre, A. Tremblay-Lebeau, and E. T. Poehlman
Metabolic and Behavioral Characteristics of Metabolically Obese but Normal-Weight Women
J. Clin. Endocrinol. Metab.,
October 1, 2004;
89(10):
5013 - 5020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Orio Jr., S. Palomba, T. Cascella, S. Di Biase, D. Labella, T. Russo, S. Savastano, F. Zullo, A. Colao, R. Vettor, et al.
Lack of an Association between Peroxisome Proliferator-Activated Receptor-{gamma} Gene Pro12Ala Polymorphism and Adiponectin Levels in the Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab.,
October 1, 2004;
89(10):
5110 - 5115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bottner, J. Kratzsch, G. Muller, T. M. Kapellen, S. Bluher, E. Keller, M. Bluher, and W. Kiess
Gender Differences of Adiponectin Levels Develop during the Progression of Puberty and Are Related to Serum Androgen Levels
J. Clin. Endocrinol. Metab.,
August 1, 2004;
89(8):
4053 - 4061.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hayashi, E. J. Boyko, D. L. Leonetti, M. J. McNeely, L. Newell-Morris, S. E. Kahn, and W. Y. Fujimoto
Visceral Adiposity Is an Independent Predictor of Incident Hypertension in Japanese Americans
Ann Intern Med,
June 15, 2004;
140(12):
992 - 1000.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Iwashima, T. Katsuya, K. Ishikawa, N. Ouchi, M. Ohishi, K. Sugimoto, Y. Fu, M. Motone, K. Yamamoto, A. Matsuo, et al.
Hypoadiponectinemia Is an Independent Risk Factor for Hypertension
Hypertension,
June 1, 2004;
43(6):
1318 - 1323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Pischon, C. J. Girman, G. S. Hotamisligil, N. Rifai, F. B. Hu, and E. B. Rimm
Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men
JAMA,
April 14, 2004;
291(14):
1730 - 1737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Calvani, A. Scarfone, L. Granato, E. V. Mora, G. Nanni, M. Castagneto, A. V. Greco, M. Manco, and G. Mingrone
Restoration of Adiponectin Pulsatility in Severely Obese Subjects After Weight Loss
Diabetes,
April 1, 2004;
53(4):
939 - 947.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Havel
Update on Adipocyte Hormones: Regulation of Energy Balance and Carbohydrate/Lipid Metabolism
Diabetes,
February 1, 2004;
53(90001):
S143 - 151.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. J.G. Hanley, P. W. Connelly, S. B. Harris, and B. Zinman
Adiponectin in a Native Canadian Population Experiencing Rapid Epidemiological Transition
Diabetes Care,
December 1, 2003;
26(12):
3219 - 3225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Snehalatha, B. Mukesh, M. Simon, V. Viswanathan, S. M. Haffner, and A. Ramachandran
Plasma Adiponectin Is an Independent Predictor of Type 2 Diabetes in Asian Indians
Diabetes Care,
December 1, 2003;
26(12):
3226 - 3229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-C. Huang, C.-L. Chen, L.-M. Chuang, S.-R. Ho, T.-Y. Tai, and W.-S. Yang
Plasma Adiponectin Levels and Blood Pressures in Nondiabetic Adolescent Females
J. Clin. Endocrinol. Metab.,
September 1, 2003;
88(9):
4130 - 4134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Orio Jr., S. Palomba, T. Cascella, G. Milan, R. Mioni, C. Pagano, F. Zullo, A. Colao, G. Lombardi, and R. Vettor
Adiponectin Levels in Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab.,
June 1, 2003;
88(6):
2619 - 2623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Faraj, P. J. Havel, S. Phelis, D. Blank, A. D. Sniderman, and K. Cianflone
Plasma Acylation-Stimulating Protein, Adiponectin, Leptin, and Ghrelin before and after Weight Loss Induced by Gastric Bypass Surgery in Morbidly Obese Subjects
J. Clin. Endocrinol. Metab.,
April 1, 2003;
88(4):
1594 - 1602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Pischon, G. S. Hotamisligil, and E. B. Rimm
Adiponectin: Stability in Plasma over 36 Hours and Within-Person Variation over 1 Year
Clin. Chem.,
April 1, 2003;
49(4):
650 - 652.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yokoe, K. Minoguchi, H. Matsuo, N. Oda, H. Minoguchi, G. Yoshino, T. Hirano, and M. Adachi
Elevated Levels of C-Reactive Protein and Interleukin-6 in Patients With Obstructive Sleep Apnea Syndrome Are Decreased by Nasal Continuous Positive Airway Pressure
Circulation,
March 4, 2003;
107(8):
1129 - 1134.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|